Story perspectives

Copenhagen's Enduro Genetics Secures €12 Million for Biomanufacturing Revolution

2/3/2025

50 10

Summary

Story summary

Copenhagen's Enduro Genetics has secured €12 million in Series A funding to propel its groundbreaking “synthetic addiction” technology, revolutionizing microbial production in biomanufacturing. This cutting-edge approach guarantees that only the most efficient cells thrive, boosting sustainability and effectiveness. The investment will fuel the expansion and commercialization of this vital innovation, tackling pressing challenges in the industry.

1 of 1

Story summary

Copenhagen's Enduro Genetics has secured €12 million in Series A funding to propel its groundbreaking “synthetic addiction” technology, revolutionizing microbial production in biomanufacturing. This cutting-edge approach guarantees that only the most efficient cells thrive, boosting sustainability and effectiveness. The investment will fuel the expansion and commercialization of this vital innovation, tackling pressing challenges in the industry.